Seres Therapeutics, Inc.
Industry: Life Sciences ・ $MCRB on Nasdaq
Insider Sale
+$1,353
-1.45%
Shares
Shares Volume: 2,505 Shares
Average Share Price: $0.54
INSIDER
Shaff Eric D.
CEO and President (Director)
reported on Nov 19 2024
traded on Nov 15 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 170,389 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $2,948.21 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 26 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $3,096.64 |
| COMPANY PREVIOUS TRADES |